Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks | Zendy

Elsa Hansen | Zendy; Troy Day | Zendy; Julien Arino | Zendy; Jian Wu | Zendy; Seyed M. Moghadas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks

Author(s) -

Elsa Hansen,

Troy Day,

Julien Arino,

Jian Wu,

Seyed M. Moghadas

Publication year - 2010

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 38

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/2010/690654

Subject(s) - zanamivir , oseltamivir , stockpile , pandemic , neuraminidase inhibitor , outbreak , medicine , psychological intervention , transmission (telecommunications) , intensive care medicine , virology , disease , infectious disease (medical specialty) , covid-19 , computer science , telecommunications , physics , psychiatry , nuclear physics

The use of neuraminidase inhibitors (oseltamivir and zanamivir) for the treatment of ill individuals has been an important intervention during the 2009 H1N1 pandemic. However, the emergence and spread of drug resistance remains a major concern and, therefore, optimizing antiviral strategies is crucial to retain the long-term effectiveness of these pharmaceutical interventions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research